Nikita Mody-Patel

Suggest Changes
Learn More
BACKGROUND AND OBJECTIVE Rivastigmine and donepezil are two cholinesterase inhibitors (ChEIs) indicated for the treatment of mild-to-moderate Alzheimer's disease. Dementia-related behavioural issues(More)
  • 1